Faes stock

Financial Times Close.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Morningstar brands and products. Investing Ideas. As of Mar 1, pm Delayed Price Closed. Unlock our analysis with Morningstar Investor.

Faes stock

Faes Farma SA operates as a pharmaceutical company. It engages in manufacturing and sale of chemical and pharmaceutical products, as well as the acquisition, purchase, sale, investment, holding, administration, management, negotiation and leasing of companies, of transferable and immovable securities, patents, trademarks and registrations and social participations. The company was founded in and is headquartered in Leioa, Spain. This browser is no longer supported at MarketWatch. For the best MarketWatch. Market Data. Latest News All Times Eastern scroll up scroll down. Can I write off my loss? How should we take this money in retirement? How can we help?

IBEX Show more Tech link Tech. Grifols S.

.

Key events shows relevant news articles on days with large price movements. Ercros SA. ECR 0. GSJ 1. Pharma Mar SA. PHM 0. Telefonica SA. TEF 0.

Faes stock

Faes Farma, S. About the company. The company's products include prescription drugs, generic drugs, over-the-counter OTC drugs, food supplements, baby foods, and other health products. Trading at

Westminster chime clocks

Watch list NEW. Morningstar brands and products. All content on FT. FTSE Almirall S. Fair Value. IBEX Sector Healthcare. Actions Add to watchlist Add to portfolio Add an alert. ET by Sarah Turner. Grifols S. Uh oh Something went wrong while loading Watchlist.

Financial Times Close. Search the FT Search. Show more World link World.

Price EUR 3. Sector Healthcare. Quick Ratio. ET by Sarah Turner. FAE Spain: Madrid. Create Watchlist …or learn more. For the best MarketWatch. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. Fair Value. Mar 1,